Improving general intelligence with a nutrient-based pharmacological intervention

Intelligence

Volumn 39, Issue 2-3, 2011, Pages 100-107

  Stough, Con ^a   Camfield, David ^a   Kure, Christina ^a   Tarasuik, Joanne ^a   Downey, Luke ^a   Lloyd, Jenny ^a   Zangara, Andrea ^a   Scholey, Andrew ^a   Reynolds, Josh ^b  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b NONE

Author keywords

Acetyl l carnitine; Alpha lipoic acid; Huperzine A; Intelligence; Rhodiola Rosea, raven progressive matrices; Vinpocetine

Indexed keywords

EID: 79953072978     PISSN: 01602896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intell.2011.01.003     Document Type: Article

References (77)

1. Abdul H.M., Calabrese V., Calvani M., Butterfield D.A. Acetyl-l-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Journal of Neuroscience Research 2006, 84(2):398-408.
2. Aureli T., Miccheli A., Di Cocco M.E., Ghirardi O., Giuliani A., Ramacci M.T., et al. Effect of acetyl-l-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat-study by 13P- and 1 H-NMR spectroscopy. Brain Research 1994, 643(1-2):92-99.
3. Azizov A.P., Seifulla R.D. The effect of elton, leveton, phytoton, and adapton on the working capacity of experimental animals. Eksperimental'naya i Klinicheskaya Farmakologiya 1998, 61(3):63.
4. Bai D.L., Tang X.C., He X.C. Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease. Current Medicinal Chemistry 2000, 7(3):355-374.
5. Beal M.F., Rascol, Marek, Olanow, Kordower, Isacson, Stocchi, Schapira, Tatton Bioenergetic approaches for neuroprotection in Parkinson's disease. Annals of Neurology 2003, 53(SUPPL. 3).
6. Buckner R.L. Memory and executive function in aging and ad: Multiple factors that cause decline and reserve factors that compensate. Neuron 2004, 44(1):195-208.
7. Darbinyan V., Kteyan A., Panossian A., Gabrielian E., Wikman G., Wagner H. Rhodiola rosea in stress induced fatigue - A double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 2000, 7(5):365-371.
8. Deary I.J., Penke L., Johnson W. The neuroscience of human intelligence differences. Nature Reviews. Neuroscience 2010, 11(3):201-211.
9. Deshmukh R., Sharma V., Mehan S., Sharma N., Bedi K.L. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - A PDE1 inhibitor. European Journal of Pharmacology 2009, 620(1-3):49-56.
10. DeShon R.P., Chan D., Weissbein D.A. Verbal overshadowing effects on Raven's advanced progressive matrices: Evidence for multidimensional performance determinants. Intelligence 1995, 21(2):135-155.
11. Dezsi L., Kis-Varga I., Nagy J., Komlodi Z., Karpati E. Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke. Acta Pharmaceutica Hungarica 2002, 72(2):84-91.
12. Dickinson D., Elvevåg B. Genes, cognition and brain through a COMT lens. Neuroscience 2009, 164(1):72-87.
13. Dolezal C., Tucek S. Utilization of citrate, acetylcarnitine, acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain slices. Journal of Neurochemistry 1981, 36(4):1323-1330.
14. Fintelmann V., Gruenwald J. Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies. Advances in Therapy 2007, 24(4):929-939.
15. Fjell A.M., Walhovd K.B. Structural brain changes in aging: Courses, causes and cognitive consequences. Reviews in the Neurosciences 2010, 21(3):187-221.
16. Giurgen C. The 'nootropic' approach to the pharmacology of the integrative activity of the brain. Conditioned Reflex 1973, 8:108-115.
17. Gulyás B., Halldin C., Sandell J., Karlsson P., Sóvágó J., Kárpáti E., et al. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects. Acta Neurologica Scandinavica 2002, 106(6):325-332.
18. Hagen T.M., Moreau R., Suh J.H., Visioli F. Mitochondrial decay in the aging rat heart: Evidence for improvement by dietary supplementation with acetyl-l-carnitine and/or lipoic acid. Annals of the New York Academy of Sciences 2002, 959:491-507.
19. Hager K., Kenklies M., McAfoose J., Engel J., Munch G. Alpha-lipoic acid as a new treatment option for Alzheimer's disease - A 48 months follow-up analysis. Journal of Neural Transmission. Supplementum 2007, 72:189-193.
20. Hager K., Marahrens A., Kenklies M., Riederer P., Munch G. Alpha-lipoic acid as a new treatment option for Azheimer type dementia. Archives of Gerontology and Geriatrics 2001, 32(3):275-282.
21. Hagiwara M., Endo T., Hidaka H. Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle. Biochemical Pharmacology 1984, 33(3):453-457.
22. Haier R.J., Siegel B.V., Nuechterlein K.H., Hazlett E., Wu J.C., Paek J., et al. Cortical glucose metabolic rate correlates of abstract reasoning and attention studied with positron emission tomography. Intelligence 1988, 12(2):199-217.
23. Halliwell B. Reactive oxygen species and the central nervous system. Journal of Neurochemistry 1992, 59(5):1609-1623.
24. Hedden T., Gabrieli J.D.E. Insights into the ageing mind: A view from cognitive neuroscience. Nature Reviews. Neuroscience 2004, 5(2):87-96.
25. Hillhouse B.J., Ming D.S., French C.J., Towers G.H.N. Acetylcholine esterase inhibitors in Rhodiola rosea. Pharmaceutical Biology 2004, 42(1):68-72.
26. Jung R.E., Haier R.J. The parieto-frontal integration theory (P-FIT) of intelligence: Converging neuroimaging evidence. The Behavioral and Brain Sciences 2007, 30(2):135-154.
27. Kelly G.S. Rhodiola rosea: A possible plant adaptogen. Alternative Medicine Review 2001, 6(3):293-302.
28. Kennedy D.O., Scholey A.B., Wesnes K.A. The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology 2000, 151(4):416-423.
29. Kidd P.M. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Alternative Medicine Review 1999, 4(3):144-161.
30. Kidd P.M. Neurodegeneration from mitochondrial insufficiency: Nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Alternative Medicine Review 2005, 10(4):268-293.
31. Kido Y., Tamai I., Ohnari A., Sai Y., Kagami T., Nezu J.I., et al. Functional relevance of carnitine transporter OCTN2 to brain distribution of l-camitine and acetyl-l-carnitine across the blood-brain barrier. Journal of Neurochemistry 2001, 79(5):959-969.
32. Lazarova M.B., Petkov V.D., Markovska V.L. Effects of meclofenoxate and Extr. Rhodiolae roseae L. on electroconvulsive shock-impaired learning and memory in rats. Methods and Findings in Experimental and Clinical Pharmacology 1986, 8(9):547-552.
33. Lee M.W., Lee Y.A., Park H.M., Toh S.H., Lee E.J., Jang H.D., et al. Antioxidative phenolic compounds from the roots of Rhodiola sachalinensis A. Bor. Archives of Pharmacal Research 2000, 23(5):455-458.
34. Li J., Wu H.M., Zhou R.L., Liu G.J., Dong B.R. Huperzine A for Alzheimer's disease. Cochrane database of systematic reviews (Online) 2008, 2.
35. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-l-carnitine and/or R-α-lipoic acid. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(4):2356-2361.
36. Maczurek A., Hager K., Kenklies M., Sharman M., Martins R., Engel J., et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Advanced Drug Delivery Reviews 2008, 60(13-14):1463-1470.
37. Maslova L.V., Kondrat'ev B.I., Maslov L.N., Lishmanov I.B. The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress. O kardioprotektorno? i antiadrenergichesko? aktivnosti ékstrakta rodioly rozovo? pri stresse 1994, 57(6):61-63.
38. Mattay V.S., Goldberg T.E., Sambataro F., Weinberger D.R. Neurobiology of cognitive aging: Insights from imaging genetics. Biological Psychology 2008, 79(1):9-22.
39. Mazzio E., Yoon K.J., Soliman K.F.A. Acetyl-l-carnitine cytoprotection against 1-methyl-4-phenylpyridinium toxicity in neuroblastoma cells. Biochemical Pharmacology 2003, 66(2):297-306.
40. Mingrone G. Carnitine in type 2 diabetes. Annals of the New York Academy of Sciences 2004, 1033:99-107.
41. Montgomery S.A., Thal L.J., Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-l-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology 2003, 18(2):61-71.
42. Packer L., Witt E.H., Tritschler H.J. Alpha-lipoic acid as a biological antioxidant. Free Radical Biology & Medicine 1995, 19(2):227-250.
43. Panossian A., Wikman G. Pharmacology of Schisandra chinensis bail: An overview of Russian research and uses in medicine. Journal of Ethnopharmacology 2008, 118(2):183-212.
44. Pereira C., Agostinho P., Moreira P.I., Duarte A.I., Santos M.S., Oliveira C.R. Neuroprotection strategies: Effect of vinpocetinein in vitro oxidative stress models. Estratégias de neuroprotecção: Efeito da vimpocetina em modelos in vitro de stresse oxidativo 2003, 16(6):401-406.
45. Petkov V.D., Yonkov D., Mosharoff A., Kambourova T., Alova L., Petkov V.V., et al. Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory. Acta Physiologica et Pharmacologica Bulgarica 1986, 12(1):3-16.
46. Prabhakaran V., Smith J.A.L., Desmond J.E., Glover G.H., Gabrieli J.D.E. Neural substrates of fluid reasoning: An fMRI study of neocortical activation during performance of the Raven's Progressive Matrices Test. Cognitive Psychology 1997, 33(1):43-63.
47. Rae C., Digney A.L., McEwan S.R., Bates T.C. Oral creatine monohydrate supplementation improves brain performance: A double-blind, placebo-controlled, cross-over trial. Proceedings of the Royal Society B: Biological Sciences 2003, 270(1529):2147-2150.
48. Raven J. Raven progressive matrices. Handbook of Nonverbal Assessment 2003, 223-237.
49. Rebouche C.J. Kinetics, pharmacokinetics, and regulation of l-carnitine and acetyl-l-carnitine metabolism. Annals of the New York Academy of Sciences 2004, 1033:30-41.
50. Rosadini G., Marenco S., Nobili F., Novellone G., Rodriguez G. Acute effects of acetyl-l-carnitine on regional cerebral blood flow in patients with brain ischaemia. International Journal of Clinical Pharmacology Research 1990, 10(1-2):123-128.
51. Ryan J., Croft K., Mori T., Wesnes K., Spong J., Downey L., et al. An examination of the effects of the antioxidant Pycnogenol on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population. Journal of Psychopharmacology 2008, 22(5):553-562.
52. Sahakian B., Morein-Zamir S. Professor's little helper. Nature 2007, 450(7173):1157-1159.
53. Santos M.S., Duarte A.I., Moreira P.I., Oliveira C.R. Synaptosomal response to oxidative stress: Effect of vinpocetine. Free Radical Research 2000, 32(1):57-66.
54. Sarkar D., Fisher P.B. Molecular mechanisms of aging-associated inflammation. Cancer Letters 2006, 236(1):13-23.
55. Schoenthaler S.J., Bier I.D., Young K., Nichols D., Jansenns S. The effect of vitamin-mineral supplementation on the intelligence of American schoolchildren: A randomized, double-blind placebo-controlled trial. Journal of Alternative and Complementary Medicine 2000, 6(1):19-29.
56. Scholey A., Ossoukhova A., Owen L., Ibarra A., Pipingas A., He K., et al. Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology 2010, 212(3):345-356.
57. Shibota M., Kakihana M., Nagaoka A. The effect of vinpocetine on the brain glucose uptake in mice. Folia Pharmacologica Japonica 1982, 80(3):221-224.
58. Silber B.Y., Papafotiou K., Croft R.J., Ogden E., Swann P., Stough C. The effects of dexamphetamine on simulated driving performance. Psychopharmacology 2005, 179(3):536-543.
59. Silber B.Y., Papafotiou K., Croft R.J., Stough C.K.K. An evaluation of the sensitivity of the standardised field sobriety tests to detect the presence of amphetamine. Psychopharmacology 2005, 182(1):153-159.
60. Snow R.E., Kyllonen P.C., Marshalek B. The topography of ability and learning correlations. Advances in the psychology of human intelligence 1984, 47-103. Lawrence Erlbaum, New Jersey. R.J. Sternberg (Ed.).
61. Spasov A.A., Wikman G.K., Mandrikov V.B., Mironova I.A., Neumoin V.V. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 2000, 7(2):85-89.
62. Spriet L.L., Dyck D.J., Cederblad G., Hultman E. Effects of fat availability on acetyl-CoA and acetylcarnitine metabolism in rat skeletal muscle. American Journal of Physiology. Cell Physiology 1992, 263(3):32-33.
63. Stough C., Clarke J., Lloyd J., Nathan P.J. Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. The International Journal of Neuropsychopharmacology 2001, 4(2):131-134.
64. Stough C., Downey L.A., Lloyd J., Silber B., Redman S., Hutchison C., et al. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 Day double-blind placebo-controlled randomized trial. Phytotherapy Research 2008, 22(12):1629-1634.
65. Stough C., Lloyd J., Clarke J., Downey L.A., Hutchison C.W., Rodgers T., et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology 2001, 156(4):481-484.
66. Stough C., Thompson J.C., Bates T.C., Nathan P.J. Examining neurochemical determinants of inspection time: Development of a biological model. Intelligence 2001, 29(6):511-522.
67. Subhan Z., Hindmarch I. Psychopharmacological effects of vinpocetine in normal healthy volunteers. European Journal of Clinical Pharmacology 1985, 28(5):567-571.
68. Szakács T., Veres Z., Vereczkey L. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine. Pharmacological Reports 2001, 53(6):623-628.
69. Tohgi H., Sasaki K., Chiba K., Nozaki Y. Effect of vinpocetine on oxygen release of hemoglobin and erythrocyte organic polyphosphate concentrations in patients with vascular dementia of the Binswanger type. Arzneimittel-Forschung/Drug Research 1990, 40(6):640-643.
70. Turner D.C., Robbins T.W., Clark L., Aron A.R., Dowson J., Sahakian B.J. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 2003, 165(3):260-269.
71. Vas Á., Gulyás B. Eburnamine derivatives and the brain. Medicinal Research Reviews 2005, 25(6):737-757.
72. Vas A., Gulyás B., Szabó Z., Bönöczk P., Csiba L., Kiss B., et al. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: A summary of evidences. Journal of the Neurological Sciences 2002, 203-204:259-262.
73. Wang R., Xi C.T. Neuroprotective effects of huperzine A: A natural cholinesterase inhibitor for the treatment of Alzheimer's disease. NeuroSignals 2005, 14(1-2):71-82.
74. Wang R., Zhang H.Y., Tang X.C. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein-(1-40) in rat. European Journal of Pharmacology 2001, 421(3):149-156.
75. Wesnes K.A., Ward T., McGinty A., Petrini O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology 2000, 152(4):353-361.
76. White H.L., Scates P.W. Acetyl-l-carnitine as a precursor of acetylcholine. Neurochemical Research 1990, 15(6):597-601.
77. Xu S.S., Gao Z.X., Weng Z., Du Z.M., Xu W.A., Yang J.S., et al. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. Acta Pharmacologica Sinica 1995, 16(5):391-395.